Abstract:SummaryBackgroundThere is little published evidence on the gastrointestinal features of COVID‐19.AimsTo report on the gastrointestinal manifestations and pathological findings of patients with COVID‐19, and to discuss the possibility of faecal transmission.MethodsWe have reviewed gastrointestinal features of, and faecal test results in, COVID‐19 from case reports and retrospective clinical studies relating to the digestive system published since the outbreak.ResultsWith an incidence of 3% (1/41)‐79% (159/201), gastrointestinal symptoms of COVID‐19 included anorexia 39.9% (55/138)‐50.2% (101/201), diarrhoea 2% (2/99)‐49.5% (146/295), vomiting 3.6% (5/138)‐66.7% (4/6), nausea 1% (1/99)‐29.4% (59/201), abdominal pain 2.2% (3/138)‐6.0% (12/201) and gastrointestinal bleeding 4% (2/52)‐13.7% (10/73). Diarrhoea was the most common gastrointestinal symptom in children and adults, with a mean duration of 4.1 ± 2.5 days, and was observed before and after diagnosis. Vomiting was more prominent in children. About 3.6% (5/138)‐15.9% (32/201) of adult and 6.5% (2/31)‐66.7% (4/6) of children patients presented vomiting. Adult and children patients can present with digestive symptoms in the absence of respiratory symptoms. The incidence of digestive manifestations was higher in the later than in the early stage of the epidemic, but no differences in digestive symptoms among different regions were found. Among the group of patients with a higher proportion of severe cases, the proportion of gastrointestinal symptoms in severe patients was higher than that in nonsevere patients (anorexia 66.7% vs 30.4%; abdominal pain 8.3% vs 0%); while in the group of patients with a lower severe rate, the proportion with gastrointestinal symptoms was similar in severe and nonsevere cases (nausea and vomiting 6.9% vs 4.6%; diarrhoea 5.8% vs 3.5%). Angiotensin converting enzyme 2 and virus nucleocapsid protein were detected in gastrointestinal epithelial cells, and infectious virus particles were isolated from faeces. Faecal PCR testing was as accurate as respiratory specimen PCR detection. In 36% (5/14)‐53% (39/73) faecal PCR became positive, 2‐5 days later than sputum PCR positive. Faecal excretion persisted after sputum excretion in 23% (17/73)‐82% (54/66) patients for 1‐11 days.ConclusionsGastrointestinal symptoms are common in patients with COVID‐19, and had an increased prevalence in the later stage of the recent epidemic in China. SARS‐CoV‐2 enters gastrointestinal epithelial cells, and the faeces of COVID‐19 patients are potentially infectious.

The effect of azathioprine, hydrocortisone and trimethazone on the occurrence of active lymphocytes in liver of endotoxin treated rabbits.

COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations

Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges

Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

COVID-19 and the digestive system: A comprehensive review

Gut Microbiota and COVID-19: Potential Implications for Disease Severity

COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens

In situ observation of nanograin rotation and deformation in nacre.

SARS-CoV-2 Spike protein triggers gut impairment since mucosal barrier to innermost layers: From basic science to clinical relevance

Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review

BACTERIAL TRANSLOCATION: MICROBIOTA-INTESTINE-LUNG AXIS AND PRO-INFLAMMATORY STATUS IN THE SEVERITY OF COVID-19

Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route

Gut Microbiome Disruption Following SARS-CoV-2: A Review

Impact of SARS-CoV2 infection on gut microbiota dysbiosis

Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis

Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management

Twelve Months with COVID-19: What Gastroenterologists Need to Know

Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19

The lung-gut axis and COVID-19

Review Article: Gastrointestinal Features in COVID‐19 and the Possibility of Faecal Transmission